Canagliflozin vs Daratumumab

## Canagliflozin vs Daratumumab: Overview

This comparison examines the pharmacological differences between **Canagliflozin** and **Daratumumab**.

## Mechanism of Action

**Canagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

## Pharmacokinetics

**Half-life**: Canagliflozin — 10.6 hours; Daratumumab — N/A.

## Chemical Properties

**Molecular Formula**: Canagliflozin — C24H25FO5S; Daratumumab — N/A.

**Molecular Weight**: Canagliflozin — 444.5170 g/mol; Daratumumab — N/A.

**Type**: Canagliflozin — Small molecule; Daratumumab — Antibody.